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ABSTRACT
Objectives: The goals of this study were to analyze the capability of brine shrimp test (BST) as a potent teratogenicity screening system on teratogenic 
agents (methotrexate, captopril, diclofenac, phenytoin, warfarin, and valproic acid).
Methods: Artemia cysts were hatched into 1st stage nauplii, then taken and put into seawater medium which contain test substance and kept alive until 
2nd stage, 3rd stage, and 4th stage, and number of deaths, morphological abnormalities, body length, and retarded of development were observed for each stage.
Results: Hatch ability of cysts in methotrexate 0.015 mg/ml, captopril 0.25 mg/ml, diclofenac 0.075 mg/ml, phenytoin 1.56 mg/ml, and valproic acid 
2.5 mg/ml were significantly different compared to control (p<0.05). Nauplii survival in methotrexate 0.015 mg/ml, captopril 0.25 mg/ml, diclofenac 
0.075 mg/ml, phenytoin 1.56 mg/ml, and valproic acid 2.5 mg/ml were significantly different to control (p<0.05). The morphological abnormalities 
was found in methotrexate 0.015 mg/ml, captopril 0.25 mg/ml. Nauplii with retarded development were expressed in methotrexate 0.015 mg/ml, 
captopril 0.25 mg/ml, diclofenac 0.075 mg/ml, phenytoin 1.56 mg/ml, and valproic acid 2.5 mg/ml. Significant difference in body length was presented 
in captopril 0.25 mg/ml, and phenytoin 1.56 mg/ml compared to control (p<0.05).
Conclusion: BST can be used as an alternative method of the teratogenic screening test, although not as sensitive teratogenic tests on mammals. This 
screening method was not suitable for a compound which its chemical characteristic can change the tonicity of the medium.
Keywords: Brine shrimp test, Teratogenicity, Methotrexate, Captopril, Diclofenac, Phenytoin, Warfarin, Valproic acid.
INTRODUCTION
Medicine for pregnant women must be safety for her and also her 
baby. Some of the medicines were contradictive for pregnant women 
because it can cause abnormality in the fetus development. The Word 
Health Organization predicted 303.000 newborns die within 4 weeks 
of birth every year, worldwide, due to congenital anomalies. Congenital 
anomalies correlated to long-term disability, which may have significant 
impacts on individuals, families, health-care systems, and societies [1].
The resolution of birth defects of the sixty-third World Health Assembly, 
promoting in primary prevention and improving in health of children 
with congenital anomalies were agreed by member states [1], by 
strengthening research and studies on etiology, diagnosing and 
preventing. One of the prevention studies is performing research 
regarding developmental toxicology or teratogenic test. Along with the 
development of science, some teratogenic testing had been developed.
Brine shrimps test is one of the teratogenic testing methods. This test 
using Crustaceans shrimp group, phylum Arthopoda, namely, Artemia 
salina L. A. salina L. cysts are more easily hatch into nauplii with rapidly 
growth. Every stage of its development can be observed, and relatively 
easy to maintain population in labotarorium condition, therefore, brine 
shrimp test (BST) is simple and effective to some biology and toxicology 
test [2].
The teratogen test system was revealed by Kerster based on disruption 
of elongation for 24 hrs and 48 hr after wetting Artemia cysts. The 
system is fast, inexpensive, requires little skill, and appropriated to test 
the teratogenicity of food additives, drugs, chemical formulations, and 
industrial wastes, but unsuited to test of gasses, particulates, very dilute 
wastes, or natural waters [3]. This study was later modified by Sleet dan 
Brendel [4], Artemia nauplii transcending instar I to later instars were 
assessed to observe their potential for indicating chemicals as potential 
developmental hazards and thus prioritizing them for more extensive 
in vivo testing. Some criterias were selected for evaluating the potential 
of the system for screening were the ability to collect homogeneous 
populations of instar I nauplii, characterize intermediate development 
by technically simple measurements and reveal development-related 
differentials in the vulnerability of nauplii. Artemia nauplii transcending 
instar I to IV useful for estimating chemicals that preferentially interact 
with developmental events [4].
The use of A. salina L. is alternative method which can replace the use 
of vertebrate animals at a higher level. This method is suitable strategy 
to streamline the testing on animals which is based on the principle of 
3 R: Alternative methods can replace the use vertebrate animals are at 
higher level (replacement), reduce the number of animals used in the 
test (reduce), choose appropriate testing method to reduce stress and 
pain in animals (refined) [5].
Methotrexate, captopril, phenytoin, diclofenac, warfarin, and valproic 
acid are a drug that classified in the category X and D by FDA, the 
class of drug in an animal study and human experiments which gave 
evidence of fetal risk. Methotrexate cause skeletal defect, low birth 
weight, and disturbed neurulation. Fetal death, neonatal anuria, 
hypoplastic calvaria can be caused by captopril. Diclofenac cause 
premature closure of the ductus arteriosus, skeletal, and heart defect. 
Warfarin cause nasal hypoplasia, central nervous system defects, and 
neurological abnormalities. Some researches stated that phenytoin and 
valproic acid can cause spina bifida, anencephaly, and other neural tube 
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defects [6-8]. Although the benefits of this drug medication is required 
contraindication for pregnant women. In special condition is used only 
if benefits are higher than the risk. The aims of this study was to analyze 
the teratogenicity screening test using BST on teratogenic substances 




Animals were A. salina L. cysts which were produced by Ocean Star 
International Inc., Utah, USA. The test substances were methotrexate, 
phenytoin, captopril, warfarin, diclofenac, and valproic acid were 
purchased from Sigma-Aldrich.
Hatching ability
As much as 10 cysts were hatched in a vial which contains 5 ml of 
seawater (with salinity 9 µg/ml) and test substance, at temperature of 
25-28°C, aerated and illuminated. After 36 hrs, hatching ability of cysts 
in each group were analyzed and the replication was performed 5 times.
Death of nauplii, morphological abnormalities, retarded 
development, and body length
As much as 1 g cysts were hatched in a beaker which contain 400 ml 
of seawater (salinity 9 µg/ml) and test substance, at a temperature 
of 25-28°C, aerated and illuminated. After hatching the 1st stage of 
Artemia nauplii (1-2 hrs after hatching) were sampled out then tested 
in each group which contain seawater and test substance. In Group 1, 
nauplii were keep alive until 2nd stage; Group 2 keep alive until 3rd stage; 
Group 3 keep alive until 4th stage. Nauplii which were taken from each 
group then put into Bouin solution for fixating. The observation was 
carried out using a microscope with a magnification of 100 times, 
with 5 times replication, included the death of nauplii, morphological 
abnormalities, retarded development and body length of nauplii.
RESULTS
Hatching ability of cyst
A number of cysts were hatched in medium seawater which contains 
teratogenic substance with various concentration in each group. 
Hatching ability of cyst in methotrexate, captopril, diclofenac, phenytoin, 
warfarin, and valproic acid can be seen in Fig. 1.
Death of nauplii
Table 1 reveals all nauplii died since the second stage (19 hrs) in 
valproic acid group. The greatest average number of mortality were 
given by captopril group and phenytoin group which had significant 
different when compared to control (p<0.005).
Morphological abnormality
Evaluation in morphological abnormality was performed in control group 
and test substances group and 5 times replication were done (Fig. 2).
Retarded development
Evaluation in all test substances groups denoted that retarded 
development was given by all teratogenic test substances (Fig. 3).
Body length
As shown in Table 2 observation in body length in all groups teratogenic 
substances. Body length of nauplii in phenytoin group gave the shortest 
of body length.
DISCUSSION
Artemia is used in this study because it is relatively easy in handling 
in the laboratory and has high tolerance when exposured by toxic 
substances. A test substance which can cause death or inhibit the 
development of Artemia means that the substance is highly toxic and 
can cause developmental disorders in other animals that tolerance is 
lower than Artemia [9,10].
Developmental toxicology test using the BST has been conducted 
by number of researchers to test the effects of several substances 
in development stages with different parameters, such as: 
Fig. 1: Hatching ability of cyst in teratogenic substances
Table 1: Death of nauplii in teratogenic substances
Test Death of nauplii (%)
Substances 2nd stage 3rd stage 4th stage
Seawater 0.00±0.00 0.00±0.00 46.70±2.31
Methotrexate 15 µg/ml 0.00±0.00 0.00±0.00 100.00±0.00*
Captopril 250 µg/ml 20.00±1.00* 60.00±3.06* 100.00±0.00*
Diclofenac 75 µg/ml 0.00±0.00 23.30±2.08 100.00±0.00*
Phenytoin 1562 µg/ml 13.30±0.58* 30.00±1.73 100.00±0.00*
Warfarin 5 µg/ml 0.00±0.00 0.00±0.00 30.00±1.73
Valproic acid 2500 µg/ml 100.00±0.00* 100.00±0.00* 100.00±0.00*
Replication is performed 5 times, n=50, * = significantly different compared to control (p<0.05)
Fig. 2: Morphological abnormality of nauplii, x, z: Arch at the 
tail, (a) Control, (b) Methotrexate, (c) Captopril 1st replication, 
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Butyrylcholinesterase in the early development of the brine shrimp 
larvae [11]; effects of copper, cadmium, and zinc on the hatching success 
of brine shrimp [12]; effects of cupric sulfate, lead nitrate, zinc sulfate and 
nickel sulfate on early life stages of the brine shrimp [13]; development-
related differentials in naupliiar vulnerability for cadmium sulfate, 
mercuric chloride, and sodium azide (NaN3) [4].
This study used five parameters of the test that is hatching cysts, death 
nauplii, abnormal morphology on nauplii, retarded development 
nauplii at each stage of development, and a body length nauplii at each 
stage of development. All of five parameters are determined based 
on Wilson’s theory, which stated that there were four manifestations 
of developmental disorders of the fetus at death, morphological 
abnormalities, growth retardation, and functional disorder. Each 
parameter is adjusted by the manifestation, except for functional 
disorders, because it is difficult to measure the functional disorders of 
the brine shrimp nauplii [14].
There were significant difference in hatching ability of cyst in 
methotrexate, captopril, diclofenac, phenytoin, warfarin and valproic 
acid compared to control group (p<0.05). The method which was used 
in this study was adopted from sargelous [15] with minor modification. 
Artemia cysts were hatching at 15-35 ppm of salinity within 24-36 
hrs [13]. Even though in this study the salinity seawater was 9 ppm, 
a significant decrease in hatching ability of cyst in a medium which 
contain teratogenic substances indicated that the substances may affect 
the development of Artemia cysts.
Survivability of nauplii at every stage was evaluated in this study. 
With the same background, increasing in mortality can be caused by 
increasing in density, turbidity, or acidity. Research by Stappen [16] 
demonstrated that density, turbidity, and acidity might change the 
tonisity of medium, which can directly affect to the survival of nauplii.
Table 1 shows that nauplii in valproic acid group could not survive, all of 
nauplii died since the second stage (19 hrs). At the second stage nauplii 
in captopril group had a greatest average number of mortality (20%). 
Mortalities in captopril group and phenytoin group (13.30%) at the 
second stage were significantly different compared to control (p<0.05). 
At the third stage, nauplii in captopril group still had a greatest number 
of mortality (60%), whereas at the fourth stage only nauplii in control 
group and warfarin group can still survive, while in the others test 
substances (methotrexate, captopril, diclofenac, phenytoin, valproic 
acid) the death of nauplii were 100%.
Observations have been performed in all groups to see abnormalities of 
morphology. The test was carried out 5 times of replication. The result 
showed that from 5 times of replication was found three defects. The 
morphological abnormalities were found in this study at the second stage 
which were two nauplii with morphological abnormalities were found in 
methotrexate group and captopril group, nauplii with amorphous form 
in methotrexate group, nauplii with arch in the tail in captopril group 
(Fig. 3). In body of adult Artemia, there are 11 pairs of torakopoda, 
the torakopoda serves as a means of motion, gills, and foragers [15]. 
Nauplii with abnormalities in any part of the body that would later 
become torakopoda, may cause disturbances in the respiratory system, 
transport, digestion, and reproduction in adult Artemia.
Nauplii different development at each stage can be observed on the 
growth and changes in anatomy [10,15]. In this study, the development 
of nauplii was observed only until the fourth stage because a lot of 
nauplii could survive until the fourth stage. All groups of teratogenic 
substances showed influence on nauplii development both at the 
second stage and the third stage, and only captopril and phenytoin 
groups at the third group were significantly different compared to 
control (Fig. 3). Sleet and Brendel [4] denoted that nauplii of Artemia 
at the first stage to the fourth stage can be used to observe the effect of 
chemical substances on the development process of Artemia nauplii [3]. 
Some tested potent teratogenic substances showed their influence on 
nauplii development although was not statistically significant. Most of 
the retarded development of nauplii which should have reached at an 
advanced stage showed anatomical characteristic at below stage. The 
retarded development may be caused the differences of hatching time of 
each cyst, therefore difficult to ascertain the retarded development was 
caused by the effect of the test substance or variety of cyst hatching time.
Body length of all teratogenic substances groups had been evaluated. Body 
length of nauplii in captopril and phenytoin groups at the second stage 
and the third stage were significantly different to control (p<0.05), and 
body length in phenytoin had the shortest body length. Nauplii of Artemia 
has a different body length at each stage of its development [15], body 
length nauplii is then measured to determine their growth disturbance 
in nauplii caused by some chemicals, differences body length in the test 
group may indicate a growth disorder in nauplii [2,3], but it can also be 
attributed to differences in hatching time.
CONCLUSION
BST can be used as an alternative method of teratogenic screening test, 
although not as sensitive teratogenic tests on mammals. This screening 
method was not suitable for a tested compound with chemical 
characteristic can change the tonicity of the medium.
Table 2: Body length of nauplii in teratogenic substances
Test Body length (µm)
Substances 2nd stage 3rd stage 4th stage
Seawater 896.70±90.86 1074.00±70.27 1505.64±90.06
Methotrexate 15 µg/ml 872.76±78.73 1019.84±38.15 -
Captopril 250 µg/ml 742.08±13.05* 906.15±3.82* -
Diclofenac 75 µg/ml 805.03±66.52 1011.56±33.37 -
Phenytoin 1562 µg/ml 736.50±22.92* 861.54±63.30* -
Warfarin 5 µg/ml 936.63±17.09 1092.19±14.21 1448.83±37.44
Valproic acid 2500 µg/ml - - -
Replication is performed 5 times, n=50, * = significantly different compared to control (p<0.05)
Fig. 3: Percentage of retarded development of nauplii
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